Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Repression of hepatitis B viral gene expression by transcription factor nuclear factor-kappaB.

Lin YC, Hsu EC, Ting LP.

Cell Microbiol. 2009 Apr;11(4):645-60. doi: 10.1111/j.1462-5822.2008.01280.x. Epub 2008 Dec 23.

PMID:
19141126
2.

Suppression of hepatitis B viral gene expression by phosphoinositide 5-phosphatase SKIP.

Hung CS, Lin YL, Wu CI, Huang CJ, Ting LP.

Cell Microbiol. 2009 Jan;11(1):37-50. doi: 10.1111/j.1462-5822.2008.01235.x. Epub 2008 Sep 4.

PMID:
18774950
3.

A novel alternatively spliced interleukin-1 receptor accessory protein mIL-1RAcP687.

Lu HL, Yang CY, Chen HC, Hung CS, Chiang YC, Ting LP.

Mol Immunol. 2008 Mar;45(5):1374-84. Epub 2007 Oct 18.

PMID:
17949817
4.

Suppression of hepatitis B viral gene expression by protein-tyrosine phosphatase PTPN3.

Hsu EC, Lin YC, Hung CS, Huang CJ, Lee MY, Yang SC, Ting LP.

J Biomed Sci. 2007 Nov;14(6):731-44. Epub 2007 Jun 24.

PMID:
17588219
5.
6.

Transcription repression of human hepatitis B virus genes by negative regulatory element-binding protein/SON.

Sun CT, Lo WY, Wang IH, Lo YH, Shiou SR, Lai CK, Ting LP.

J Biol Chem. 2001 Jun 29;276(26):24059-67. Epub 2001 Apr 16.

7.

Hepatitis B virus core protein interacts with the C-terminal region of actin-binding protein.

Huang CJ, Chen YH, Ting LP.

J Biomed Sci. 2000 Mar-Apr;7(2):160-8.

PMID:
10754391
8.
9.
10.
11.

Differential regulation of major surface promoter in hepatitis B virus.

Kuo YL, Ting LP.

DNA Cell Biol. 1997 May;16(5):545-57.

PMID:
9174160
12.
14.
15.

Expression and localization of the small and large delta antigens during the replication cycle of hepatitis D virus.

Wu JC, Chen CL, Lee SD, Sheen IJ, Ting LP.

Hepatology. 1992 Nov;16(5):1120-7.

PMID:
1427653
16.
18.

Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line.

Wu JC, Chen PJ, Kuo MY, Lee SD, Chen DS, Ting LP.

J Virol. 1991 Mar;65(3):1099-104.

20.

Sexual transmission of hepatitis D virus infection in Taiwan.

Wu JC, Lee SD, Govindarajan S, Lin HC, Chou P, Wang YJ, Lee SY, Tsai YT, Lo KJ, Ting LP.

Hepatology. 1990 Jun;11(6):1057-61.

PMID:
2365283
21.

Correlation of serum delta RNA with clinical course of acute hepatitis delta virus superinfection in Taiwan: a longitudinal study.

Wu JC, Lee SD, Govindarajan S, Kung TW, Tsai YT, Lo KJ, Ting LP.

J Infect Dis. 1990 Jun;161(6):1116-20.

PMID:
2345295
22.

Isoniazid-rifampin-induced hepatitis in hepatitis B carriers.

Wu JC, Lee SD, Yeh PF, Chan CY, Wang YJ, Huang YS, Tsai YT, Lee PY, Ting LP, Lo KJ.

Gastroenterology. 1990 Feb;98(2):502-4.

PMID:
2295408
23.
24.

Insulin suppresses hepatitis B surface antigen expression in human hepatoma cells.

Chou CK, Su TS, Chang CM, Hu CP, Huang MY, Suen CS, Chou NW, Ting LP.

J Biol Chem. 1989 Sep 15;264(26):15304-8.

25.
26.

Insulin-induced expression of human heat-shock protein gene hsp70.

Ting LP, Tu CL, Chou CK.

J Biol Chem. 1989 Feb 25;264(6):3404-8.

27.

Expression of class I and class II major histocompatibility antigens on human hepatocellular carcinoma.

Sung CH, Hu CP, Hsu HC, Ng AK, Chou CK, Ting LP, Su TS, Han SH, Chang CM.

J Clin Invest. 1989 Feb;83(2):421-9.

28.

Cytochemical localization and biochemical analysis of the enzyme markers in human hepatoma cell lines.

Chao CF, Chen JY, Tseng YM, Ting LP.

Proc Natl Sci Counc Repub China B. 1988 Oct;12(4):222-7.

PMID:
2907658
29.

Expression of oncogenes in human hepatoma cell lines.

Ting LP, Jeng KS, Chou CK, Su TS, Hu CP, Wong FH, Chang HK, Chang CM.

Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1988 Aug;21(3):141-50.

PMID:
2854043
30.

Symptomatic anti-HBe positive chronic hepatitis B in Taiwan with special reference to persistent HBV replication and HDV superinfection.

Wu JC, Lee SD, Tsay SH, Tsai YT, Chan CY, Huang YS, Lo KJ, Ting LP.

J Med Virol. 1988 Jun;25(2):141-8.

PMID:
3392522
31.

Evidence of autocrine regulation in human hepatoma cell lines.

Tsai TF, Yauk YK, Chou CK, Ting LP, Chang C, Hu CP, Han SH, Su TS.

Biochem Biophys Res Commun. 1988 May 31;153(1):39-45.

PMID:
2837209
32.

Characterization of nucleotide sequence of hepatitis B surface gene and enhancer element of HBV.

Ting LP, Chang HK.

Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1987 Aug;20(3):224-40.

PMID:
3428015
33.

Monoclonal antibodies against human esophageal carcinoma cell lines.

Hsieh HG, Hu CP, Han SH, Chen LR, Chien KY, Chou CK, Ting LP, Su TS, Huang MH, Hsu WH, et al.

Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1987 Aug;20(3):179-89.

PMID:
2827967
34.

The enhancer sequence of human hepatitis B virus can enhance the activity of its surface gene promoter.

Chang HK, Chou CK, Chang C, Su TS, Hu C, Yoshida M, Ting LP.

Nucleic Acids Res. 1987 Mar 11;15(5):2261-8.

35.

Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line.

Chang CM, Jeng KS, Hu CP, Lo SJ, Su TS, Ting LP, Chou CK, Han SH, Pfaff E, Salfeld J, et al.

EMBO J. 1987 Mar;6(3):675-80.

36.

Correlation between hepatic hepatitis B core antigen and serum hepatitis B virus-DNA levels in patients with chronic hepatitis B virus infections in Taiwan.

Wu JC, Lee SD, Wang JY, Ting LP, Tsai YT, Tsay SH, Tong MJ.

Arch Pathol Lab Med. 1987 Feb;111(2):181-4.

PMID:
3545139
37.

Selective suppression of insulin-induced proliferation of cultured human hepatoma cells by somatostatin.

Chou CK, Ho LT, Ting LP, Hu CP, Su TS, Chang WC, Suen CS, Huang MY, Chang CM.

J Clin Invest. 1987 Jan;79(1):175-8.

38.

Hepatitis B virus transcripts in a human hepatoma cell line, Hep 3B.

Su TS, Lin LH, Chou CK, Chang CM, Ting LP, Hu CP, Han SH.

Biochem Biophys Res Commun. 1986 Jul 16;138(1):131-8.

PMID:
3017312
39.

Expression of hepatitis B surface antigen by yeast actin gene promoter.

Ting LP, Chang HK, Chiang CS.

Biochem Biophys Res Commun. 1986 May 14;136(3):1063-70.

PMID:
3013163
40.

Prevention of maternal-infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA.

Lee SD, Lo KJ, Wu JC, Tsai YT, Wang JY, Ting LP, Tong MJ.

Hepatology. 1986 May-Jun;6(3):369-73.

PMID:
3710425
41.

Analysis of the DNA of hepatitis B virus in the sera of Chinese patients infected with hepatitis B.

Wu JC, Lee SD, Wang JY, Ting LP, Tsai YT, Lo KJ, Chiang BN, Tong MJ.

J Infect Dis. 1986 May;153(5):974-7. No abstract available.

PMID:
3701109
42.

Expression of c-myc gene in human hepatoma.

Su TS, Lin LH, Lui WY, Chang CM, Chou CK, Ting LP, Hu CP, Han SH, P'eng FK.

Biochem Biophys Res Commun. 1985 Oct 15;132(1):264-8.

PMID:
2415125
43.

Characterization of restriction endonuclease maps of hepatitis B viral DNAs.

Lo SJ, Lee YH, Chiou JS, Ting LP, Liu WT, Choo KB.

Biochem Biophys Res Commun. 1985 Jun 28;129(3):797-803.

PMID:
2990468
44.

Restriction endonuclease mapping of the hepatitis B viral genome isolated from Taiwan.

Lee YH, Lo SJ, Chiou JS, Ting LP, Liu WT, Choo KB.

Proc Natl Sci Counc Repub China B. 1985 Apr;9(2):110-8.

PMID:
2996043
45.

Efficiency of proton extrusion by chemically modified mitochondria.

Ting LP, Wang JH.

Biochim Biophys Acta. 1982 Dec 15;682(3):474-81.

PMID:
7150581
46.
47.

2,4,6-Trinitrobenzenesulfonate labels an essential amino group near the bound phosphate at the catalytic site of mitochondrial F1-ATPase.

Ting LP, Wang JH.

Biochem Biophys Res Commun. 1981 Aug 14;101(3):934-8. No abstract available.

PMID:
6458293
48.

Functional groups at the catalytic site of F1 adenosine triphosphatase.

Ting LP, Wang JH.

Biochemistry. 1980 Dec 9;19(25):5665-70.

PMID:
6450612
49.

Supplemental Content

Support Center